CN1243755C - 用于制备头孢菌素的偶合方法和中间体 - Google Patents

用于制备头孢菌素的偶合方法和中间体 Download PDF

Info

Publication number
CN1243755C
CN1243755C CNB018199623A CN01819962A CN1243755C CN 1243755 C CN1243755 C CN 1243755C CN B018199623 A CNB018199623 A CN B018199623A CN 01819962 A CN01819962 A CN 01819962A CN 1243755 C CN1243755 C CN 1243755C
Authority
CN
China
Prior art keywords
alkyl
formula
compound
aryl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018199623A
Other languages
English (en)
Chinese (zh)
Other versions
CN1478093A (zh
Inventor
J·C·库尔博格
A·康纳德利
G·弗格利亚托
M·齐诺尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CN1478093A publication Critical patent/CN1478093A/zh
Application granted granted Critical
Publication of CN1243755C publication Critical patent/CN1243755C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CNB018199623A 2000-12-04 2001-11-22 用于制备头孢菌素的偶合方法和中间体 Expired - Fee Related CN1243755C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25101400P 2000-12-04 2000-12-04
US60/251,014 2000-12-04

Publications (2)

Publication Number Publication Date
CN1478093A CN1478093A (zh) 2004-02-25
CN1243755C true CN1243755C (zh) 2006-03-01

Family

ID=22950114

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018199623A Expired - Fee Related CN1243755C (zh) 2000-12-04 2001-11-22 用于制备头孢菌素的偶合方法和中间体

Country Status (17)

Country Link
US (2) US20020198375A1 (enExample)
EP (1) EP1339722A1 (enExample)
JP (1) JP2004520293A (enExample)
KR (1) KR100526379B1 (enExample)
CN (1) CN1243755C (enExample)
AR (1) AR035511A1 (enExample)
AU (2) AU2394302A (enExample)
BR (1) BR0115870A (enExample)
CA (1) CA2436848C (enExample)
CZ (1) CZ20031525A3 (enExample)
HU (1) HUP0400642A3 (enExample)
IL (1) IL155714A0 (enExample)
MX (1) MXPA03004937A (enExample)
PL (1) PL362144A1 (enExample)
RU (1) RU2237670C1 (enExample)
WO (1) WO2002046198A1 (enExample)
ZA (1) ZA200303670B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111892612A (zh) * 2020-07-31 2020-11-06 重庆医药高等专科学校 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030051895A (ko) * 2000-12-04 2003-06-25 후지사와 야꾸힝 고교 가부시키가이샤 아미노티아졸 유도체의 무수물의 제조 방법
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
RU2321590C1 (ru) * 2004-03-09 2008-04-10 Пфайзер Продактс Инк. Способ получения промежуточных соединений цефалоспорина с использованием сложных эфиров альфа-йод-1-азетидинуксусной кислоты и триалкилфосфитов
SG194779A1 (en) 2011-05-04 2013-12-30 Univ Cornell Multiblock copolymer films, methods of making same, and uses thereof
EP2740730B1 (en) 2011-08-03 2016-11-16 Kyowa Hakko Kirin Co., Ltd. Dibenzooxepin derivative
CN102718779B (zh) * 2012-05-25 2015-07-29 深圳致君制药有限公司 注射用头孢唑肟钠及其制备方法、原料药头孢唑肟钠的合成方法
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
WO2018229580A1 (en) * 2017-06-14 2018-12-20 Aurobindo Pharma Ltd An improved process for the preparation of cefovecin sodium
EP3697524A4 (en) 2017-09-19 2021-09-01 Terapore Technologies, Inc. CHEMICALLY RESISTANT ISOPOROUS CROSS-LINKED BLOCK COPOLYMER STRUCTURE
EP3774003A4 (en) * 2018-04-04 2022-01-05 Terapore Technologies, Inc. ENCAPSULATION PARTICLE FRACTIONATION DEVICES AND SYSTEMS AND THEIR METHODS OF USE
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
US11051804B2 (en) * 2018-07-02 2021-07-06 DePuy Synthes Products, Inc. Orthopedic fixation system and method of use thereof
CN110396034A (zh) * 2019-07-31 2019-11-01 上海应用技术大学 一种烯丙基化合物的制备方法
CN111187284A (zh) * 2020-03-10 2020-05-22 赵俊瑶 一种头孢克洛的制备方法
CN112321611B (zh) * 2020-10-29 2022-05-06 湖北凌晟药业有限公司 一种头孢沙定母核的制备方法
CN115873021A (zh) * 2022-12-19 2023-03-31 华北制药集团动物保健品有限责任公司 一种头孢维星钠的制备方法
CN116731039B (zh) * 2023-06-12 2025-02-18 重庆汉佩生物科技有限公司 头孢维星衍生物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106399A (en) * 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
US6001997A (en) * 1990-07-24 1999-12-14 Bateson; John Hargreaves Cephalosporins and homologues, preparations and pharmaceutical compositions
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
DE60117876T2 (de) * 2000-12-04 2006-08-31 Pfizer Products Inc., Groton Verfahren und esterderivate zur herstellung von cephalosphorinen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111892612A (zh) * 2020-07-31 2020-11-06 重庆医药高等专科学校 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法

Also Published As

Publication number Publication date
HK1059435A1 (en) 2004-07-02
CA2436848C (en) 2008-12-02
BR0115870A (pt) 2004-02-03
MXPA03004937A (es) 2003-09-10
AU2002223943B2 (en) 2006-10-05
JP2004520293A (ja) 2004-07-08
WO2002046198A1 (en) 2002-06-13
ZA200303670B (en) 2004-05-13
HUP0400642A3 (en) 2010-03-29
AU2394302A (en) 2002-06-18
RU2237670C1 (ru) 2004-10-10
CZ20031525A3 (cs) 2004-04-14
US20020198375A1 (en) 2002-12-26
IL155714A0 (en) 2003-11-23
US20040167327A1 (en) 2004-08-26
EP1339722A1 (en) 2003-09-03
CA2436848A1 (en) 2002-06-13
KR100526379B1 (ko) 2005-11-08
PL362144A1 (en) 2004-10-18
CN1478093A (zh) 2004-02-25
KR20030070043A (ko) 2003-08-27
HUP0400642A2 (hu) 2004-06-28
AR035511A1 (es) 2004-06-02
US7129350B2 (en) 2006-10-31

Similar Documents

Publication Publication Date Title
CN1243755C (zh) 用于制备头孢菌素的偶合方法和中间体
CN1194980C (zh) 膦酰基头孢烯衍生物,其制备和用途
CN1015178B (zh) β-内酰胺抗菌素中间体的制备方法
CN1046523C (zh) 制备抗菌剂喹诺酮内酰胺的方法
AU2002223943A1 (en) Coupling process and intermediates useful for preparing cephalosphorins
CN1060778C (zh) 头孢菌素衍生物
CN87107149A (zh) 7-[(间位取代的)苯基甘氨酸]1-碳代-1-去硫头孢菌素
CN1181072C (zh) 用于制备碱性抗生素·无机酸盐的方法和草酸盐中间体
CN1107679C (zh) 3－(2－取代－乙烯基)头孢菌素的z异构体的选择性制造方法
CN1044246C (zh) 双环β－内酰胺/对羟苯甲酸酯复合物
CN1243756C (zh) 用于制备头孢菌素的方法和酯衍生物
CN100347179C (zh) 经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法
CN1253458C (zh) 物质gm－95的制备方法
HK1059435B (zh) 用於制备头孢菌素的偶合方法和中间体
CN1080265C (zh) 7－烷氧烷基－1,2,4－三唑并[1,5－a]嘧啶衍生物的制备方法
CN1309713C (zh) 制备头孢菌素侧链的方法
CN1226245C (zh) 卤化剂和羟基的卤化方法
CN1044280A (zh) 头孢菌素衍生物及其制备方法
CN1282652C (zh) 3－氯甲基－3－头孢烯衍生物结晶的制造方法
CN1653061A (zh) 喹诺酮羧酸衍生物的制备方法
CN1090185C (zh) 有双环氨基取代的吡啶酮羧酸衍生物,其酯及盐,以及可用作其中间体的双环类胺
WO2007037303A1 (ja) テトラ置換－５－アザスピロ[２．４]へプタン誘導体の製法およびその光学活性中間体
JPS63211283A (ja) 抗菌剤
CN1606558A (zh) 新型头孢菌素化合物及其制备方法
HK1027089B (en) Halogenating agent and process for halogenating hydroxyl group

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1059435

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060301

Termination date: 20091222